InsideArbitrage Event Driven Monitor – November 22, 2022
Quick updates on the event-driven strategies we follow on InsideArbitrage. Merger Arbitrage Imago BioSciences (IMGO) to be acquired by Merck (MRK) for $848.46 million or $36 per share in cash. Alcon (ALC) completes the acquisition of Aerie Pharmaceuticals (AERI). F-star Therapeutics (FSTX) and Sino Biopharmaceutical Limited amended their merger agreement by extending the end date from November 19, 2022, to December 19, 2022. The parties are in discussions with the Committee on Foreign Investment in the United States (CFIUS) regarding the transaction and have extended the end date to provide for additional time to satisfy the Foreign Investment Condition with respect to CFIUS. Johnson & Johnson (JNJ) filed with the Austria Federal Competition Authority for its proposed acquisition of Abiomed (ABMD). The EU Commission disclosed that it has extended its deadline for a decision on Microsoft’s (MSFT) proposed acquisition of Activision Blizzard (ATVI) to 11 April 2023. Yamana Gold (AUY) announced that the special meeting of stockholders will be on January 31, 2023. Deal in the Works – Update Activist investor Irenic Capital Management has suggested a spin-off of the media company’s digital real estate business or Dow Jones as an alternative to its merger with Fox Corp (FOXA). Insider Purchases Patrick G. Ryan, the Chief Executive Officer of specialty insurance company Ryan Specialty Holdings,...
Only plus or premium subscribers can access this post. Subscribe today.
